Dana Bohan

机构：VIR Biotechnology (United States) · ORCID：0000-0002-9239-3053

发表论文 21 篇 · 总被引 611 次 · h-index 10

代表论文

• Neutralization, effector function and immune imprinting of Omicron variants (2023 · Nature · 被引 182)
• Phosphatidylserine receptors enhance SARS-CoV-2 infection (2021 · PLoS Pathogens · 被引 134)
• A potent pan-sarbecovirus neutralizing antibody resilient to epitope diversification (2024 · Cell · 被引 70)
• Human Organotypic Airway and Lung Organoid Cells of Bronchiolar and Alveolar Differentiation Are Permissive to Infection by Influenza and SARS-CoV-2 Respiratory Virus (2022 · Frontiers in Cellular and Infection Microbiology · 被引 48)
• IL-4/IL-13 polarization of macrophages enhances Ebola virus glycoprotein-dependent infection (2019 · PLoS neglected tropical diseases · 被引 34)
• Therapeutic and vaccine-induced cross-reactive antibodies with effector function against emerging Omicron variants (2023 · bioRxiv (Cold Spring Harbor Laboratory) · 被引 31)